Free Trial

Surgery Partners (SGRY) Stock Price, News & Analysis

Surgery Partners logo
$15.11 -0.20 (-1.31%)
As of 03:12 PM Eastern
This is a fair market value price provided by Massive. Learn more.

About Surgery Partners Stock (NASDAQ:SGRY)

Advanced

Key Stats

Today's Range
$15.06
$15.51
50-Day Range
$12.18
$15.31
52-Week Range
$11.41
$24.10
Volume
458,316 shs
Average Volume
1.53 million shs
Market Capitalization
$1.98 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$22.18
Consensus Rating
Moderate Buy

Company Overview

Surgery Partners Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
81st Percentile Overall Score

SGRY MarketRank™: 

Surgery Partners scored higher than 81% of companies evaluated by MarketBeat, and ranked 131st out of 859 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Surgery Partners has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 1 strong buy rating, 8 buy ratings, 2 hold ratings, and 1 sell rating.

  • Upside Potential

    Surgery Partners has a consensus price target of $22.18, representing about 47.0% upside from its current price of $15.09.

  • Amount of Analyst Coverage

    Surgery Partners has only been the subject of 3 research reports in the past 90 days.

  • Read more about Surgery Partners' stock forecast and price target.
  • Earnings Growth

    Earnings for Surgery Partners are expected to grow by 68.42% in the coming year, from $0.19 to $0.32 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Surgery Partners is -25.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Surgery Partners is -25.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    Surgery Partners has a PEG Ratio of 5.90. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Surgery Partners has a P/B Ratio of 0.62. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Surgery Partners' valuation and earnings.
  • Percentage of Shares Shorted

    10.70% of the float of Surgery Partners has been sold short.
  • Short Interest Ratio / Days to Cover

    Surgery Partners has a short interest ratio ("days to cover") of 11.64, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Surgery Partners has recently decreased by 5.29%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Surgery Partners does not currently pay a dividend.

  • Dividend Growth

    Surgery Partners does not have a long track record of dividend growth.

  • News Sentiment

    Surgery Partners has a news sentiment score of 1.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.86 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Surgery Partners this week, compared to 3 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Surgery Partners insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $365,226.00 in company stock.

  • Percentage Held by Insiders

    2.00% of the stock of Surgery Partners is held by insiders.

  • Percentage Held by Institutions

    Surgery Partners has minimal institutional ownership at this time.

  • Read more about Surgery Partners' insider trading history.
Receive SGRY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Surgery Partners and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SGRY Stock News Headlines

SpaceX IPO hides a much bigger story
The SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. Elon believes what Michael Robinson calls 'Project Unlimited' could unlock $100 trillion in potential growth. One little-known company sits at the center of it all, and most investors have no idea it exists. Position yourself before this company potentially hits the front page.tc pixel
See More Headlines

SGRY Stock Analysis - Frequently Asked Questions

Surgery Partners' stock was trading at $15.45 on January 1st, 2026. Since then, SGRY stock has decreased by 2.4% and is now trading at $15.0850.

Surgery Partners, Inc. (NASDAQ:SGRY) posted its quarterly earnings data on Tuesday, May, 5th. The company reported ($0.03) EPS for the quarter, beating analysts' consensus estimates of ($0.15) by $0.12. The firm's revenue was up 4.5% compared to the same quarter last year.
Read the conference call transcript
.

Surgery Partners' Board of Directors initiated a stock buyback program on Thursday, February 26th 2026, which authorizes the company to repurchase $200,000,000 in shares, according to EventVestor. This means that the company could purchase up to 9.7% of its shares through open market purchases. Shares buyback programs are often a sign that the company's board believes its stock is undervalued.

Surgery Partners (SGRY) raised $350 million in an initial public offering (IPO) on Thursday, October 1st 2015. The company issued 14,285,000 shares at a price of $23.00-$26.00 per share.

Top institutional shareholders of Surgery Partners include Janus Henderson Group PLC (10.35%), Dimensional Fund Advisors LP (4.05%), Hsbc Holdings PLC (1.46%) and Bank of America Corp DE (0.95%). Insiders that own company stock include Andrew T Kaplan, Jason Eric Evans, Jennifer Baldock, David T Doherty, Wayne S Deveydt, Harrison R Bane, Marissa Brittenham, Danielle Burkhalter, William Trenton Webb, Bradley R Owens and Teresa Deluca.
View institutional ownership trends
.

Shares of SGRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Surgery Partners investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), Palo Alto Networks (PANW), ServiceNow (NOW) and Adobe (ADBE).

Company Calendar

Last Earnings
5/05/2026
Today
6/15/2026
Next Earnings (Estimated)
8/04/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Services
Sub-Industry
Healthcare
Current Symbol
NASDAQ:SGRY
CIK
1638833
Employees
16,000
Year Founded
2004

Price Target and Rating

High Price Target
$36.00
Low Price Target
$14.00
Potential Upside/Downside
+46.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
12 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.60)
Trailing P/E Ratio
N/A
Forward P/E Ratio
79.47
P/E Growth
5.9
Net Income
-$77.90 million
Net Margins
-2.28%
Pretax Margin
3.41%
Return on Equity
1.04%
Return on Assets
0.41%

Debt

Debt-to-Equity Ratio
1.17
Current Ratio
1.86
Quick Ratio
1.69

Sales & Book Value

Annual Sales
$3.31 billion
Price / Sales
0.60
Cash Flow
$1.68 per share
Price / Cash Flow
8.97
Book Value
$24.21 per share
Price / Book
0.62

Miscellaneous

Outstanding Shares
130,790,000
Free Float
128,172,000
Market Cap
$1.97 billion
Optionable
Optionable
Beta
1.96

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:SGRY) was last updated on 6/15/2026 by MarketBeat.com Staff.
From Our Partners